Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of hepatitis C virus related liver fibrosis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

319

HTML

3208

Figures (1-2)

220

Tables (1-5)

175

Sum=3922

Jan 27, 2012 (publication date) through Oct 2, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Hepatol. Jan 27, 2012; 4(1): 11-17
Published online Jan 27, 2012. doi: 10.4254/wjh.v4.i1.11

Table 3 Glycated albumin/glycated hemoglobin ratio for the detection of cirrhosis (F4), severe fibrosis (F3-F4) and significant fibrosis (F2-F4) (%)

	F4	F0-F3	F3-F4	F0-F2	F2-F4	F0-F1
GA/HbA1c > 3.0	16/27 (59.3)	34/115 (29.6)	28/56 (50.0)	22/86 (25.6)	36/81 (44.4)	14/61 (23.0)
GA/HbA1c ≤ 3.0	11/27 (40.7)	81/115 (70.4)	28/56 (50.0)	64/86 (74.4)	45/81 (55.6)	47/61 (77.0)

GA/HbA1c: Glycated albumin/glycated hemoglobin.

Citation: Aizawa N, Enomoto H, Imanishi H, Saito M, Iwata Y, Tanaka H, Ikeda N, Sakai Y, Takashima T, Iwai T, Moriwaki EI, Shimomura S, Iijima H, Nakamura H, Nishiguchi S. Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of hepatitis C virus related liver fibrosis. World J Hepatol 2012; 4(1): 11-17
URL: https://www.wjgnet.com/1948-5182/full/v4/i1/11.htm
DOI: https://dx.doi.org/10.4254/wjh.v4.i1.11